High diagnostic discrepancy in infectious diseases detected by autopsy

Main Article Content

Aldo Guadalupe Cisneros-Aréchiga https://orcid.org/0009-0008-4916-8986
Maribel Avila-Morán https://orcid.org/0000-0002-4903-1671
Gladis Razo-Jiménez https://orcid.org/0009-0009-3203-6773
Jazmin Márquez-Pedroza https://orcid.org/0000-0003-2859-726X
Blanca Miriam Torres-Mendoza https://orcid.org/0000-0003-2233-571X

Keywords

Autopsy, Diagnostic Errors, Communicable Diseases, Immunocompromised Host

Abstract

Background: Autopsies are considered the gold standard for determining the cause of death. Infections are among the leading causes of death, and many are only identified through autopsy. Such studies are lacking in Mexico.


Objective: To compare the frequency of diagnostic discrepancies, particularly those related to infections identified premortem, in patients from the Hospital de Especialidades del Centro Médico Nacional de Occidente, during the period from 2014 to 2021.


Materials and methods: A retrospective study was conducted. Autopsy reports from 2014 to 2021 were reviewed to identify cases with infectious diagnoses determined postmortem. Premortem diagnoses were obtained from clinical records. Two clinical reviewers classified the diagnostic discrepancies. Inter-rater agreement was assessed using Cohen’s Kappa coefficient and comparison were performed using the Chi-square test.


Results: Of 164 autopsies, 70 cases (43%) revealed at least one infection as either the primary or a contributing cause of death. Diagnostic discrepancies were identified in 52% of patients with infections and in 70% of patients living with HIV. The most frequent infectious disease was pneumonia, while cytomegalovirus (CMV) and Candida were the most commonly underdiagnosed infections.


Conclusions: Diagnostic discrepancies are present in more than half of the patients with infectious diseases. The HIV-positive population has the highest rate of diagnostic discrepancies.

Abstract 0 | PDF (Spanish) Downloads 0

References

1. Shubhendu K, Mundri S, Kumar S, et al. The Impact of Histopathology on Medical Board Autopsies. Cureus. 2025;17(2):e78675. doi:10.7759/cureus.78675

2. Graber ML. Progress understanding diagnosis and diagnostic errors: thoughts at year 10. Diagnosis. 2020;7:151-9.

3. Breiman RF, Blau DM, Mutevedzi P, et al. Postmortem investigations and identification of multiple causes of child deaths: an analysis of findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) network. PLoS Med. 2021;18-19.

4. van den Tweel JG, Wittekind C. The medical autopsy as quality assurance tool in clinical medicine: dreams and realities. Virchows Arch. 2016;468(1):75-81.

5. Eshaghi S, Sheybani F, Hedjazi A, et al. Infectious Causes of Death: An Autopsy-Based Study of 546 Cases. Open Forum Infect Dis. 2025;12(2):ofaf065.

6. Bonds LA, Gaido L, Woods JE, et al. Infectious diseases detected at autopsy at an urban public hospital, 1996-2001. Am J Clin Pathol. 2003;119(6):866-872.

7. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;400(10358):1102. doi: 10.1016/S0140-6736(21)02653-2

8. Ritter JM, Sei xas JN, Walong E, et al. Histopathology is Key to Interpreting Multiplex Molecular Test results from Postmortem minimally invasive tissue samples. Clin Infect Dis. 2021;73 Supplement5:S351-9.

9. Magrupov BA, Sharipova VK, Ubaydullaeva VU, et al. Sopostavlenie zaklyuchitel'nogo klinicheskogo i patologo-anatomicheskogo diagnozov pri sepsise [Comparison of the final clinical and autopsy detected diagnoses in sepsis]. Arkh Patol. 2022;84(4):38-44. doi: 10.17116/patol20228404138

10. World Health Organization. The International Statistical Classification of Diseases and Related Health Problems, Tenth revision. WHO, Geneva. 2019.

11. Ángeles A, Quintanilla L, Muñoz L, et al. Concordancia diagnóstica clínico-patológica en 429 autopsias del Instituto Nacional de la Nutrición Salvador Zubirán. Rev Invest Clín. 1992;44(1):13-20.

12. Beadsworth MBJ, Cohen D, Ratcliffe L, et al. Autopsies in HIV: Still identifying missed diagnoses. Int J STD AIDS. 2009 Feb;20(2):84-6.

13. Borges AS, Rocha A, Silva AM, et al. Agreement between premortem and postmortem diagnoses in patients with acquired immunodeficiency syndrome observed at a Brazilian teaching hospital. Rev Ins Med Trop São Paulo. 1997;39:217-21.

14. Eza D, Cerrillo G, Castro C, et al. Resultados post mortem e infecciones oportunistas en pacientes VIH-positivos de un hospital público del Perú. Rev Peru Med Exp Salud Publica. 2006;23(4).

15. Parkhomenko IG, Tishkevich OA, Shakhgil’dian VI. Analysis of autopsies in HIV infection. Arkh Patol. 2003;65(3):24-9.

16. Del Rio C. Autopsy Findings Among Persons Who Died with HIV in New York. NEJM Journal Watch. 2019;1984-2016.

17. Martín del Campo-Rodríguez LE, Sifuentes-Osornio J. Infecciones oportunistas en el síndrome de inmunodeficiencia adquirida: La historia en México a 20 años del inicio de la epidemia. Rev Invest Clín. 2004;56(2):169-80.

18. INEGI. Características de las defunciones registradas en México durante 2020 . www.inegi.org.mx. 2021.

19. Machorro-Cano I, Ríos-Méndez IA, Palet-Guzmán JA, et al. Medical Opinions Analysis about the Decrease of Autopsies Using Emerging Pattern Mining. Data. 2024;9(1):2.

20. Abraham S, Ghosh S. Tracking Missing Deaths: An Exploratory Study on the Mortality Impact of COVID-19 in Kozhikode City, India. Indian J Public Health. 2024;68(2):227-232.

21. Al Nemer A. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects. Adv Anat Pathol. 2020;27(6):363-370.

22. Multani A, Allard LS, Wangjam T, et al. Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: An autopsy study. Blood Adv. 2019;3(22):3602-12.

23. Hailu R, Desta T, Bekuretsion Y, et al. Minimally Invasive Tissue Sampling in Preterm Deaths: A Validation Study. Glob Pediatr Health. 2020;7:2333794X20953263.

24. Paganelli CR, Goco NJ, McClure EM, et al. The evolution of minimally invasive tissue sampling in postmortem examination: a narrative review. Glob Health Action. 2020;13:14.

25. Wareham-Mathiassen S, Nateqi M, Badrinarayanan SA, et al. Evaluating antimicrobial efficacy in medical devices: The critical role of simulating in use test conditions. Biomater Adv. 2025;172:214241.